2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | - | - | - | - | - | - | 0 | 112.035 | 251.481 | 259.930 |
Total Income - EUR | - | - | - | - | - | - | 2 | 137.325 | 242.274 | 264.193 |
Total Expenses - EUR | - | - | - | - | - | - | 792 | 135.049 | 257.411 | 239.857 |
Gross Profit/Loss - EUR | - | - | - | - | - | - | -790 | 2.276 | -15.138 | 24.336 |
Net Profit/Loss - EUR | - | - | - | - | - | - | -790 | 1.154 | -17.652 | 21.737 |
Employees | - | - | - | - | - | - | 0 | 2 | 1 | 2 |
Check the financial reports for the company - Premium Biofruct S.r.l.
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Check Financial Rating2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 139.220 | 159.569 | 164.429 | 106.136 | - | - | - | - | - | - |
Current Assets | - | - | - | - | - | - | 81.841 | 274.589 | 202.734 | 220.481 |
Inventories | - | - | - | - | - | - | 44.589 | 146.065 | 64.218 | 67.459 |
Receivables | - | - | - | - | - | - | 26.422 | 41.103 | 42.618 | 117.672 |
Cash | - | - | - | - | - | - | 10.830 | 87.421 | 95.898 | 35.349 |
Shareholders Funds | - | - | - | - | - | - | 1.277 | 2.401 | -17.178 | 4.611 |
Social Capital | - | - | - | - | - | - | 2.067 | 2.022 | 2.028 | 2.022 |
Debts | - | - | - | - | - | - | 212.526 | 471.132 | 414.675 | 356.230 |
Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "1032 - 1032" | |||||||||
CAEN Financial Year | 1032 |
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Reports that can be accessed based on the subscription:
Get the contact details for any company and get in touch with it.